nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Are some agents less likely to deposit gadolinium in the brain?
|
Radbruch, Alexander |
|
2016 |
34 |
10 |
p. 1351-1354 4 p. |
artikel |
2 |
Can gadolinium be re-chelated in vivo? Considerations from decorporation therapy
|
Prybylski, John P. |
|
2016 |
34 |
10 |
p. 1391-1393 3 p. |
artikel |
3 |
Contents
|
|
|
2016 |
34 |
10 |
p. iii-iv nvt p. |
artikel |
4 |
Editorial Board
|
|
|
2016 |
34 |
10 |
p. IFC- 1 p. |
artikel |
5 |
Gadolinium based contrast agents (GBCA): Safety overview after 3 decades of clinical experience
|
Kanal, Emanuel |
|
2016 |
34 |
10 |
p. 1341-1345 5 p. |
artikel |
6 |
Gadolinium deposition disease: Initial description of a disease that has been around for a while
|
Semelka, Richard C. |
|
2016 |
34 |
10 |
p. 1383-1390 8 p. |
artikel |
7 |
Gadolinium deposition in the brain
|
Kanda, Tomonori |
|
2016 |
34 |
10 |
p. 1346-1350 5 p. |
artikel |
8 |
Gadolinium deposition in the brain: Lessons learned from other metals known to cross the blood–brain barrier
|
Prybylski, John P. |
|
2016 |
34 |
10 |
p. 1366-1372 7 p. |
artikel |
9 |
Gadolinium deposition: Is it chelated or dissociated gadolinium? How can we tell?
|
Tweedle, Michael F. |
|
2016 |
34 |
10 |
p. 1377-1382 6 p. |
artikel |
10 |
Gadolinium tissue deposition in brain and bone
|
Murata, Nozomu |
|
2016 |
34 |
10 |
p. 1359-1365 7 p. |
artikel |
11 |
Gadolinium toxicity and treatment
|
Ramalho, Joana |
|
2016 |
34 |
10 |
p. 1394-1398 5 p. |
artikel |
12 |
Gadolinium toxicity: Iron and ferroportin as central targets
|
Swaminathan, Sundararaman |
|
2016 |
34 |
10 |
p. 1373-1376 4 p. |
artikel |
13 |
Summary of special issue on gadolinium bioeffects and toxicity with a look to the future
|
Semelka, Richard C. |
|
2016 |
34 |
10 |
p. 1399-1401 3 p. |
artikel |
14 |
Technical aspects of MRI signal change quantification after gadolinium-based contrast agents' administration
|
Ramalho, Joana |
|
2016 |
34 |
10 |
p. 1355-1358 4 p. |
artikel |